• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在以食物维持反应的大鼠中,CB1拮抗剂产生的行为与饱腹感更为一致,而非奖励价值降低。

CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.

作者信息

Thompson Emily E, Jagielo-Miller Julia E, Vemuri V Kiran, Makriyannis Alexandros, McLaughlin Peter J

机构信息

Department of Psychology, Edinboro University of Pennsylvania, Edinboro, PA, USA.

Center for Drug Discovery, Northeastern University, Boston, MA, USA.

出版信息

J Psychopharmacol. 2016 May;30(5):482-91. doi: 10.1177/0269881116639287. Epub 2016 Mar 22.

DOI:10.1177/0269881116639287
PMID:27005309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5531753/
Abstract

Cannabinoid CB1 antagonists are widely known to reduce motivation for food, but it is not known whether they induce satiety or reduce reward value of food. It may therefore be necessary to compare effects of altered satiety and reward food value in the same appetitive task, and determine whether CB1 antagonism produces a behavior pattern similar to either, both, or neither. A fine-grained analysis of fixed-ratio 10 (FR10) responding for palatable food initially included number and duration of, and between, all lever presses and food tray entries in order to differentiate the pattern of suppression of prefeeding from that caused by reducing the reward value of the pellets with quinine. Discriminant function analysis then determined that these manipulations were best differentiated by effects on tray entries, pellet retrieval latencies, and time of the first response. At 0.5 mg/kg, AM 6527 produced similar effects to reducing reward value, but at 1.0 and 4.0 mg/kg, effects were more similar to those when animals were satiated. We conclude that AM 6527 both reduced reward value and enhanced satiety, but as dose increased, effects on satiety became much more prominent. These findings contribute to knowledge about the behavioral processes affected by CB1 antagonism.

摘要

大麻素CB1拮抗剂能降低对食物的欲望,这一点广为人知,但尚不清楚它们是诱导饱腹感还是降低食物的奖励价值。因此,可能有必要在同一食欲任务中比较改变饱腹感和奖励食物价值的效果,并确定CB1拮抗作用是否会产生与其中一种、两种或都不相似的行为模式。对美味食物进行固定比率10(FR10)反应的精细分析最初包括所有杠杆按压和食物托盘进入的次数、持续时间以及两者之间的间隔,以便区分预喂食抑制模式与用奎宁降低颗粒奖励价值所导致的模式。判别函数分析随后确定,这些操作最好通过对托盘进入、颗粒取回潜伏期和首次反应时间的影响来区分。在0.5毫克/千克时,AM 6527产生的效果与降低奖励价值相似,但在1.0和4.0毫克/千克时,效果更类似于动物处于饱腹状态时的效果。我们得出结论,AM 6527既能降低奖励价值又能增强饱腹感,但随着剂量增加,对饱腹感的影响变得更加显著。这些发现有助于了解受CB1拮抗作用影响的行为过程。

相似文献

1
CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.在以食物维持反应的大鼠中,CB1拮抗剂产生的行为与饱腹感更为一致,而非奖励价值降低。
J Psychopharmacol. 2016 May;30(5):482-91. doi: 10.1177/0269881116639287. Epub 2016 Mar 22.
2
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.大麻素CB1拮抗剂和多巴胺拮抗剂对一项涉及觅食行为中反应分配和努力相关选择的任务产生不同影响。
Psychopharmacology (Berl). 2008 Mar;196(4):565-74. doi: 10.1007/s00213-007-0988-4. Epub 2007 Nov 15.
3
The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.大麻素CB1受体反向激动剂AM 251和拮抗剂AM 4113对大鼠行为饱腹感序列产生相似的影响。
Behav Brain Res. 2008 Nov 21;193(2):298-305. doi: 10.1016/j.bbr.2008.06.010. Epub 2008 Jun 17.
4
AM 251 differentially effects food-maintained responding depending on food palatability.AM 251 会根据食物的可口程度对食物维持的反应产生不同的影响。
Pharmacol Biochem Behav. 2010 Jun;95(4):443-8. doi: 10.1016/j.pbb.2010.03.005. Epub 2010 Mar 21.
5
The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.大麻素CB1拮抗剂AM 251会导致大鼠出现食物回避以及与恶心相关的行为,但不会损害其进食效率。
Psychopharmacology (Berl). 2005 Jul;180(2):286-93. doi: 10.1007/s00213-005-2171-0. Epub 2005 Mar 15.
6
Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.新型CB1受体拮抗剂/反向激动剂AM 1387对食物摄入和食物强化行为的抑制作用
Pharmacol Biochem Behav. 2006 Mar;83(3):396-402. doi: 10.1016/j.pbb.2006.02.022. Epub 2006 Mar 6.
7
Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.大麻素CB1受体拮抗剂利莫那班对大鼠巧克力味饮料强化和激励特性的抑制作用。
Behav Pharmacol. 2008 May;19(3):197-209. doi: 10.1097/FBP.0b013e3282fe8888.
8
The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.大麻素CB1受体拮抗剂SR141716A可降低对食物的食欲和进食反应。
Psychopharmacology (Berl). 2005 May;179(2):452-60. doi: 10.1007/s00213-004-2047-8. Epub 2004 Nov 18.
9
Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.大麻素CB1受体拮抗剂利莫那班(SR141716)对喹氯烷增强食物引发的觅食行为恢复的阻断作用。
Neuropsychopharmacology. 2004 May;29(5):911-20. doi: 10.1038/sj.npp.1300370.
10
Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.大麻素CB1受体拮抗剂可减弱可卡因的奖赏效应:大鼠自我给药及脑刺激奖赏实验
Neuropsychopharmacology. 2008 Jun;33(7):1735-45. doi: 10.1038/sj.npp.1301552. Epub 2007 Aug 29.

引用本文的文献

1
The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence.内源性大麻素系统与进食行为:当前证据综述。
Curr Nutr Rep. 2022 Dec;11(4):665-674. doi: 10.1007/s13668-022-00436-x. Epub 2022 Aug 18.
2
"Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "-On" CBR Antagonist.“光瑞莫那班”:新型光致变色瑞莫那班类似物的合成与生物评价,得到一个高选择性和纳摩尔级的“开”型 CB1 拮抗剂。
ACS Chem Neurosci. 2021 May 5;12(9):1632-1647. doi: 10.1021/acschemneuro.1c00086. Epub 2021 Apr 15.
3

本文引用的文献

1
A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents.关于大麻素1受体拮抗剂作为抗肥胖药物的全面专利综述。
Expert Opin Ther Pat. 2015;25(10):1093-116. doi: 10.1517/13543776.2015.1064898. Epub 2015 Jul 10.
2
Slave to habit? Obesity is associated with decreased behavioural sensitivity to reward devaluation.习惯的奴隶?肥胖与行为对奖赏贬值的敏感性降低有关。
Appetite. 2015 Apr;87:175-83. doi: 10.1016/j.appet.2014.12.212. Epub 2014 Dec 24.
3
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.
内源性大麻素通过与多巴胺和内源性阿片样物质信号相互作用调节奖赏和强化。
Neuropsychopharmacology. 2018 Jan;43(1):103-115. doi: 10.1038/npp.2017.126. Epub 2017 Jun 27.
4
Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT receptor.大麻素CB1反向激动剂和拮抗剂对雄性斯普拉格-道利大鼠冲动性的不同影响:确定一种可能与临床相关的涉及血清素5HT受体的易感性。
Psychopharmacology (Berl). 2017 Mar;234(6):1029-1043. doi: 10.1007/s00213-017-4548-2. Epub 2017 Feb 1.
5
Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?饮食中的类大麻素植物化学物质——与食物选择和代谢应激适应的进化联系?
Br J Pharmacol. 2017 Jun;174(11):1464-1483. doi: 10.1111/bph.13676. Epub 2017 Jan 16.
6
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.分级糖皮质激素-内源性大麻素相互作用调节胰岛素对伏隔核的激活。
Brain Res Bull. 2016 Jun;124:222-30. doi: 10.1016/j.brainresbull.2016.05.009. Epub 2016 May 18.
CB1拮抗剂:对大鼠急性纳洛酮诱发的吗啡戒断情感特性的干扰
Psychopharmacology (Berl). 2014 Nov;231(22):4291-300. doi: 10.1007/s00213-014-3575-5. Epub 2014 Apr 27.
4
The endocannabinoid system controls food intake via olfactory processes.内源性大麻素系统通过嗅觉过程控制食物摄入。
Nat Neurosci. 2014 Mar;17(3):407-15. doi: 10.1038/nn.3647. Epub 2014 Feb 9.
5
Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.在大鼠按照低比率操作反应分化强化程序做出反应时,氯胺酮而非MK-801会产生类抗抑郁作用。
Behav Pharmacol. 2014 Feb;25(1):80-91. doi: 10.1097/FBP.0000000000000014.
6
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.交感神经系统的激活介导了 CB₁ 受体阻断的食欲减退和类似焦虑的效应。
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4786-91. doi: 10.1073/pnas.1218573110. Epub 2013 Mar 4.
7
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.肝脏大麻素1受体作为肝脏能量状态和食物摄入的调节因子。
Br J Clin Pharmacol. 2014 Jan;77(1):21-30. doi: 10.1111/bcp.12102.
8
The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions.选择性 5-羟色胺再摄取抑制剂帕罗西汀降低了大鼠在进行蔗糖和奎宁溶液递增比例舔食任务时的作用点。
Chem Senses. 2013 Mar;38(3):211-20. doi: 10.1093/chemse/bjs096. Epub 2012 Dec 19.
9
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.低剂量纳洛酮可减弱雷莫芦单抗引起的雄性大鼠瘙痒但不影响食欲减退反应。
Psychopharmacology (Berl). 2013 Mar;226(2):415-31. doi: 10.1007/s00213-012-2916-5. Epub 2012 Nov 10.
10
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.外周型大麻素 1 型受体反向激动剂通过逆转瘦素抵抗减轻肥胖。
Cell Metab. 2012 Aug 8;16(2):167-79. doi: 10.1016/j.cmet.2012.07.002. Epub 2012 Jul 26.